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a b s t r a c t 
The diffusion of medical devices is expanding at an astonishing rate. The increasing number of novel 
patents per year suggests this growth will continue. In contrast to drugs, medical devices are intrinsically 
dependent on the environment in which they are used and how they are maintained. This created an un- 
precedented global need for well-trained biomedical engineers who can help healthcare systems to assess 
them. The International Federation for Medical and Biological Engineering (IFMBE) is the global scientific 
society of biomedical engineers in official relations with the United Nations World Health Organisation 
(WHO) and has been very active in promoting the role of the biomedical engineer in Health Technol- 
ogy Assessment (HTA). The IFMBE Health Technology Assessment Division (HTAD) is the IFMBE operative 
branch in this field, promoting studies, projects and activities to foster the growth of this specific and 
very important science sector, including summer schools, training material, an HTA eLearning platform, 
HTA guidelines, awards and more. This article describes the vision, the mission and the strategy of the 
HTAD, with a focus on the results achieved and the impact this is having on global policymaking. 
© 2019 The Authors. Published by Elsevier Ltd on behalf of IPEM. 
This is an open access article under the CC BY license. ( http://creativecommons.org/licenses/by/4.0/ ) 
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(. Introduction 
The past 10 years has seen a remarkable diffusion of Medical
evices (MDs). A proxy for future diffusion is the number of MD
atent applications submitted per year [1] . While the yearly num-
er of patent applications per pharmaceuticals and biotechnolo-
ies remains at a constant level year after year (about 60 0 0 novel
atent applications per year since 2006), the number of patents
or medical technologies only keeps growing at a remarkable rate,
oving from 90 0 0 to more than 12,0 0 0 novel patent applications
er year during the period 2006–2016 in Europe only [2] . Simi-
ar figures come from the United States of America (US), where
atent filings show a significant uptrend from 2007 (about 22,000
pplications) to 2018 (more than 34,0 0 0 applications). Should we
onsider this latter figure valid today, we could speculate that it
quates to more than 93 novel patent applications per day, sug-
esting that while you are reading this manuscript three to four
D novel patent applications could have been filed. In addition,∗ Corresponding author at: School of Engineering, University of Warwick, Coven- 
ry, UK. 
E-mail address: l.pecchia@warwick.ac.uk (L. Pecchia). 
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350-4533/© 2019 The Authors. Published by Elsevier Ltd on behalf of IPEM. This is an op
 http://creativecommons.org/licenses/by/4.0/ ) or many MDs, the time to market (TTM) has become shorter and
horter over the past years. The combination of those two trends
i.e., increased number of MD patent applications and shorter TTM)
as already resulted in an unprecedented increase of novel MDs in-
roduced in the market each year: a veritable ‘tsunami’ of medical
evices! [3] . 
There is no doubt that the increase in quality and quantity of
Ds has played a key role in the general improvement of global
ealth as reported by the World Bank and the World Health Organ-
sation (WHO) indicators (e.g., under-five mortality rate has never
een so low [4] ; life expectancy at birth has never been so long
5] etc.). However, huge disparities persist between high- and low-
ncome settings, the former being where the majority of global
opulation is diagnosed and treated [6] . 
Nonetheless, the exceptional availability of MDs, at least in
igher-income countries, generated an exceptional request for
ovel profiles of professionals and scholars, highly qualified for
upporting healthcare systems in assessing, procuring, managing
nd decommissioning MDs. The peculiarities of MDs require spe-
ific knowledge if compared to other healthcare technologies such
s drugs or surgical procedures [7] . 
An extraordinary global [8] political interest has grown around
he role of biomedical engineers and their contribution to theen access article under the CC BY license. 
20 L. Pecchia, N. Pallikarakis and R. Magjarevic et al. / Medical Engineering and Physics 72 (2019) 19–26 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
t  
e  
l
 
i  
n  
(  
o  
T  
S  
C  
b  
t  
i
2
 
t  
H  
I  
o  
a  
i  
g  
2
 
c  
b  
e  
v
 
 
 
 
 
 
 
2
 
f  
d
 
 
 
 
 
 
 
 
 
 
 
 
 
holders. Health Technology Assessment (HTA) in connecting researchers to
policy maker communities [9] . 
In 2014 the World Health Organisation (WHO) stated that
‘t rained and qualified biomedical engineering professionals are re-
quired to design, evaluate, regulate, maintain and manage Medical
Devices, and train on their safe use in health systems around the
world ’ [10] . In response to this statement, the European Economic
and Social Committee (SEEC) engaged in close consultation with
the European community of Biomedical Engineers represented by
the European Alliance for Medical and Biological Engineering and
Science (EAMBES) [11] . This discussion resulted in a study pub-
lished in April 2015 (2015/C 291/07) in the Euro Lex (the official
Journal of the European Union) stating that: ‘ Biomedical Engineering
is not simply a subset of modern medicine. Modern medicine predom-
inantly secures important advances through the use of the products of
biomedical engineering ’ [12] . 
Referring to HTA knowledge, the Biomedical Engineering (BME)
community has been lagging behind other healthcare scientific
communities (e.g., pharma, medicine, health economy), in terms of
available training, discussion fora and also in defining HTA as one
of the core topics for BME. Although some universities had intro-
duced HTA topics in their curricula, it was only in 2011 that HTA
was proposed as a core topic for BME by a consortium of Euro-
pean Universities [13–15] endorsed by the International Federation
of Medical and Biological Engineering (IFMBE) [16] . 
This article describes the effort of the global community of
Biomedical Engineers in talking these emerging challenges to fos-
ter the HTA culture among the BME community through the work
of the Health Technology Assessment Division (HTAD) of the IFMBE
between 2015 and 2018. 
1.1. Global community of BME 
The IFMBE is the global scientific society of Biomedical Engi-
neers, federating 66 national societies from 60 different countries
and 6 transnational societies (IEEE EMBS, EAMBES, ACCE, AAMI,
CAHTMA and CORAL). These professional organisations represent
the global interests in medical and biological engineering in the
world. The IFMBE is also a Non-Governmental Organisation (NGO)
in official relations with the United Nations World Health Organ-
isation (WHO), which IFMBE serves as recognised stakeholder of-
fering continuous support and expertise for delivering better and
more accessible health care to the world, through a unique net-
work of world leading experts of biomedical and clinical engineer-
ing. 
The IFMBE governance is entrusted to five Officers (President,
President-Elect, Past-President, Treasurer and Secretary General),
which are elected by the IFMBE General Assembly during the
World Congresses of Medical Physics and Biomedical Engineering.
The officers are supported by the Administrative Council, whose
members are in part elected during the General Assembly (4 mem-
bers) and in part appointed ex-officio as Chairs of the Council of
Societies, Fellows’ Chapter and Divisions. 
Important bodies of the IFMBE are the two Division: the IFMBE
Health Technology Assessment Division (HTAD) [17] and the IFMBE
Clinical Engineering Division (CED) [18] , which together account
for a large part of the IFMBE activities and budget. Division board
members are elected during the IFMBE General Assembly among
candidates nominated by IFMBE Affiliated societies. Those mem-
bers are considered to be experts of HTA or Clinical Engineering.
Among those elected board members, seven per Division, the Chair,
the Secretary and the Treasurer are then elected. They are respon-
sible for coordinating the Divisions’ activities and reporting about
their achievements to the IFMBE Administrative Council. 
It is worth remarking that the all activities and work done for
the IFMBE is on voluntary base, and none of the AC or Division
members is compensated for their contributions by the IFMBE. The IFMBE Division can also propose to the IFMBE President
wo additional board members to be co-opted on the base of their
xpertise. Finally, both Divisions have a significant number of col-
aborators directly appointed by Division Chairs. 
The IFMBE teamed up the International Organisation for Med-
cal Physicists (IOMP) into a larger association named the Inter-
ational Union for Physical and Engineering Sciences in Medicine
IUPESM). These three organisations coordinate the World Congress
n Medical Physics and Biomedical Engineering every three years.
he forthcoming World Congress will be held in Singapore in late
pring 2021. IUPESM is a member of the International Science
ouncil (ISC), an NGO in official relations with the UN UNESCO,
ringing together 40 international scientific Unions and Associa-
ions and over 140 national and regional scientific organisations
ncluding Academies and Research Councils. 
. Method 
Through a series of focus groups and scoping literature reviews,
he IFMBE HTAD elected and co-opted members defined the IFMBE
TAD Vision, Mission and Strategy. Once these where defined, the
FMBE HTAD Chair discussed and agreed with the IFMBE Officers
n a three-year plan and program of activities. A series of surveys
nd numerous focus groups were run along the years, aiming at
nvolving international scholars, promoting the Division activities,
etting feedback and for continuously improving ongoing activities.
.1. Vision 
The IFMBE HTAD vision is that biomedical engineers “should be
onstantly involved in HTA studies focusing on MDs, in order to
etter serve the ultimate beneficiary of healthcare and biomedical
ngineering: the patient”. The Vision is based on three enabling
alues: 
• The expertise of Biomedical Engineers (unlike other HTA ex-
perts) spans across MD research, design, assessment and man-
agement; 
• biomedical engineering has a multi-disciplinary nature, consid-
ering that biomedical engineers are employed in MD research
and manufacturing as well as in hospitals and healthcare agen-
cies; 
• biomedical engineering has an inter-disciplinary nature, with
BME students specifically educated in a wide range of topics,
including physics, math, engineering, biology and medicine. 
.2. Mission 
In order to achieve the above vision, the IFMBE HTAD per-
ormed a scoping review and a gap analysis, which resulted in the
efinition of four focus areas: 
• Training: due to the lack of specific training material and
courses suitable for biomedical engineers, the Division aimed
to develop specific training events and contents on HTA, based
on BME educational needs and background, which are different
from those of other HTA experts. 
• Research: reinforce the collaboration among BME scholars
proactively involved in HTA research and studies. 
• Publications: in order to fill the dearth of publication fora (i.e.,
conference and journals) for HTA research outcomes, often due
to lack of HTA experts in the BME community, the HTAD board
decided to support the IFMBE Conference Organizers and jour-
nal editors, by helping them in identifying networks of local ex-
perts and by providing them with a direct support. 
• Events: organizing scientific events and workshops aiming at
promotion collaboration among biomedical engineers, scientific
societies with interest in HTA, policy makers and HTA stake-
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Figure 1. Participants of summer schools on HTA for BME organised by the IFMBE 
HTAD respectively in 2015 (left) and 2017 (right). 
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b.3. Strategy 
In order to accomplish this mission, the IFMBE HTAD defined an
rticulated plan, made of 5 strategic goals further structured in 11
riority projects, aiming to overcome fragmentation and avoiding
orking “in silos”: 
• Establishing periodical training events on HTA for biomedical
engineers, 
• Developing and sharing free high-quality training material on
HTA for biomedical engineers; 
• Reinforcing collaboration on HTA among biomedical engineers
and other HTA experts; 
• Creating new spaces to facilitate BME publications on HTA; and
• Preparing IFMBE recommendations and guidelines for HTA. 
Ten priority projects of the HTAD were defined: 
(1) Organise HTA summer schools for biomedical engineers : start-
ing a series of IFMBE Summer Schools on HTA, to be organ-
ised in different regions every 2 years; 
(2) Develop HTA training material : publishing high quality HTA
didactic contents, which could respond to biomedical engi-
neers’ learning needs; 
(3) Launch eLearning platform : designing, refining and managing
a web portal and an eLearning platform to spread HTA con-
tents and promote BME experiences in HTA initiatives; 
(4) Foster HTA collaboration : fostering international collaboration
among biomedical engineers active in HTA, supporting stu-
dents and early career researchers’ mobility by providing
funds to set new collaborations and organizing writing ses-
sions to apply for future grants on collaborative actions on
HTA; 
(5) Support HTA strategic communication : aiming at reinforcing
HTA related communication and exchange of experience and
knowledge with other scientific societies, agencies and pol-
icy makers; 
(6) Preparing guidelines and recommendations : promoting studies
in HTA areas of particular interest for biomedical engineers,
including early HTA (pre-market HTA studies) and HTA for
medical devices, to develop IFMBE guidelines for MDs as-
sessment; 
(7) Fostering capacity building in LMICs : HTA-related capacity
building in the LMICs (focusing on Africa in the first 3
years); 
(8) Continuous monitoring on biomedical engineering in HTA : a
survey to monitor BME involvement in HTA; 
(9) Establishing and promoting IFMBE HTA Awards aiming at rec-
ognizing emerging BME talents in HTA, policy actions pro-
moting BME involvement in HTA and individuals providing
outstanding contribution to the promotion of biomedical en-
gineering and 
(10) Supporting the WHO in the area of HTA of MDs by providing
BME knowledge 
Each project was coordinated by a division elected or co-opted
ember together with a team of collaborators. Many projects were
un in strict collaboration with ongoing projects led by partner in-
titutions, in order to avoid duplications and maximise communi-
ation and impact. 
.4. Ethical approvals 
When required, ethical approvals where sought at the home in-
titutions of project coordinators. . Results 
.1. HTA summer schools for Biomedical Engineers 
The first IFMBE HTAD Summer School was held in the UK, at
he Warwick University in September 2015. The course was struc-
ured in three days. The first day an introduction to underlying
oncepts of HTA was offered, or ganised in three topics: evidence
eneration in medicine; systematic literature review; fundamentals
f health economics. The second day was dedicated to the HTA of
D, introducing the main difference between medical devices and
ther healthcare technologies, and presenting methodological im-
lications and existing tools, which could be used to assess med-
cal devices. The third and last day was focused on two relevant
opics for biomedical engineers: early stage HTA and Multi-Criteria
ecision Making (MCDA) for HTA. Each day was organised in two
essions: frontal lectures were held in the morning, while the af-
ernoon was open for practical group work facilitated by lectur-
rs and tutors. Lectures were given from professors coming from
even countries: Croatia, Italy, Luxemburg, The Netherlands, Spain,
K and USA. The second Summer School was held at the University
f Patras, Greece, in September 2107, following the same structure
f the first edition ( Fig. 1 ). 
Further details and the detailed programs are published on the
FMBE HTAD website [17] . 
.2. HTA training material 
This project aimed at developing HTA training material, specif-
cally designed considering the needs of biomedical engineers. A
uick survey run in 2015 revealed that many biomedical engi-
eers struggled using training material that was conceived for
ther scholars. The survey has identified five main aspects per-
eived as gaps: limited use of equations and schematic workflows;
oor attention and limited examples on MDs; widespread use of
erbose paragraphs; lack of attention to pre-market HTA, which is
opic of great interest for many BME scholars; little or no atten-
ion to methods and tools (e.g., MCDA) to assist decision-making
n healthcare. 
All the lecturers participating to the IFMBE HTAD Summer
chools, agreed to create and share handouts specifically meant for
n engineering audience. In addition, all the lectures given during
hose two summer schools where videotaped and became eLearn-
ng objects. 
A gap-analysis revealed which essential HTA topics were miss-
ng from the two summer schools. IFMBE HTAD elected, co-opted
nd collaborator members volunteered to videotape lectures or
eynotes given to IFMBE conferences to complete the missing sub-
ects. This resulted in a significant production of novel HTA train-
ng material specifically designed for BME. Part of this material is
reely accessible via the IFMBE HTAD eLearning platform, while the
andouts are under review for publication on an upcoming open-
ook. 
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Figure 2. Distribution of users of the IFMBE eLearning platform since its launch. 
From left: 76 users from 14 countries in August 2017; 722 users from 48 countries 
in August 2018; 1423 users from 70 different countries in August 2019. 
Figure 3. HTAD working groups meetings at the University of Warwick in Novem- 
ber 2016 (left) and in Tampere in June 2017 (right). 
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vices, medical facilities and healthcare professionals. 3.3. eLearning platform 
The HTA didactic material produces is freely available on the
IFMBE HTA eLearning platform, accessible via the IFMBE HTAD
website [17] . It contains more than 30 h of HTA lectures organ-
ised in nine sections each composed by a variable number of
presentations: 
(1) Introduction to HTA: this section contains basic and ad-
vanced lectures to fundamental topics of HTA and health
economics: 
(a) Intro to health economics & HTA of medical devices
(Dr. Leandro Pecchia) 
(b) HTA, an Introduction (Dr. Patrizio Armeni) 
(2) Evidence generation in medicine 
(a) Evidence generation in medicine and biomedical engi-
neering (Dr. L Pecchia) 
(b) Evidence generation in medicine (Prof. S. Stranges) 
(c) The value proposition: promise versus evidence (Prof. D
Clark) 
(3) Systematic literature review and meta-analysis 
(a) Evidence based BME and meta-analysis (Dr. L Pecchia) 
(b) Introduction to the meta-analysis (Dr. P Melillo) 
(c) Practical lab on meta-analysis with OpenMetaAnalyst
(Dr. P Melillo) 
(d) Meta-analysis with missing data (Dr. P Melillo) 
(4) Multi-criteria decision analysis (MCDA) 
(a) Multi-criteria decision analysis (MCDA) for Early HTA
(Dr. M Hummel) 
(b) Multi-criteria decision analysis (MCDA) in eHTA (Dr. L
Pecchia) 
(c) Analytic hierarchy process and data-mining (Dr. P
Melillo) 
(d) Multiple criteria decision aiding (MCDA) and its poten-
tials to support sustainability and resilience assessment
(Dr. M Cinelli) 
(5) IFMBE HTAD activities 
(a) IFMBE HTAD activities 2015–2017 (Dr. L Pecchia) 
(b) Introduction to the II IFMBE HTAD Summer School (Prof
N Pallikarakis) 
(c) Introduction to the first IFMBE Summer School on HTA
(Dr. L Pecchia) 
(6) Early HTA 
(a) Early health economic evaluations & eHTA (Dr. L Pecchia)
(b) Early stage HTA via decision tree (Dr. M Craven) 
(c) Early sStage HTA via Markov models (Dr. M Craven) 
(d) Multi-criteria decision analysis (MCDA) in eHTA (Dr. M
Hummel) 
(7) HTA of medical devices 
(a) The industry of medical devices & medical devices regu-
lation of in the EU (Prof. N Pallikarakis) 
(b) The industry, the regulation and the challenges in assess-
ing medical devices (Prof. R Tarricone) 
(c) Institutional HTA: the European perspective (Dr. O. Ciani)
(d) Medical device assessments at CADTH (Dr. J. Polisena) 
(8) User need elicitation 
(a) User-need elicitation via AHP (Dr. L. Pecchia) 
(b) MCDA in user need elicitation for HTA (Dr. L. Pecchia) 
(9) WHO, BME, medical devices and global health 
(a) Selection of priority medical devices (A. Velazquez,
WHO) 
(b) The role of BME to develop appropriate technologies for
low- middle-income countries and settings (A. Velazquez,
WHO) 
Launched in September 2016, the eLearning platform has had
a significant and fast-growing number of users, from the entire
world ( Fig. 2 ), 76 different users from 14 countries in August 2017,22 users from 48 countries in August 2018 and eventually 1423
sers from 70 different countries in August 2019. It is certainly
mpressive, although expected, to see that the majority of users ac-
essed the platform contents from the ‘Great South’, where there
s a large number of LMICS, and the highest need for HTA, aiming
o optimize the shortness of economic resources. 
.4. HTA collaborative 
The HTAD has supported several face-to-face meetings, often
eld during IFMBE conferences in order to facilitate experts’ par-
icipation, given their busy agenda. 
In order to prepare the IFMBE recommendation on the HTA of
Ds, two focus groups were organised ( Fig. 3 ): 15 IFMBE HTAD
embers and collaborators were invited for a 2-day structured
ocus group convened in 2016 November 26th and 27th, at the
chool of Engineering at the University of Warwick; the second fo-
us group was convened in Tampere, Finland, in June 16th, 2017. 
.5. HTA strategic communication 
This project was conceived for fostering HTA-related communi-
ation and exchange of experience and knowledge among the BME
ommunity as represented by the IFMBE and other scientific soci-
ties, agencies and policy makers. This project, as many others, was
un in strict collaboration with other IFMBE Divisions and working
roups, IFMBE affiliated societies, IFMBE HTAD collaborators and
artner institutions. This activity was focused on three main ac-
ions: 
• Collecting evidence to support the ongoing discussion among
the IFMBE, WHO, UN ILO (United Nation International Labour
Organisation) and the European Parliament for stronger recog-
nition of BME as a profession. 
• Establishing stable collaboration among the European biomedi-
cal engineering community and the European Parliament, aim-
ing at mutual informing on political and other initiatives re-
garding medical devices regulation, management and assess-
ment and fostering the ongoing discussion among relevant Eu-
ropean and African institutions with the purpose of promoting
the harmonisation of directives and regulations on medical de-
L. Pecchia, N. Pallikarakis and R. Magjarevic et al. / Medical Engineering and Physics 72 (2019) 19–26 23 
Figure 4. The flowchart of the survey on global numbers on biomedical engineers 
and biomedical technicians. 
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Figure 5. EPIG on BME meetings: two top photos are from the 1st meeting in May 
2015, the two on the bottom are from the 2nd meeting in October 2018. 
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L  
j  
t  Regarding the stronger recognition of BME as a profession, the
FMBE has had an intensive discussion with the WHO aiming at
nsuring that this profession will be listed in the next edition of
he ILO International Standard Classification of Occupation (ISCO).
he ILO global repository of occupations is recognised by UN mem-
er states, and consequently transferred to nationally regulations.
he current version of this classification is the ISCO-08, which was
dopted through a resolution of a Tripartite Meeting of Experts
n Labour Statistics held in December 2007 and subsequently en-
orsed by the Governing Body of the ILO in March 2008. According
o ISCO, BME is listed in the category 2149 ‘ Engineering profession-
ls not elsewhere recognised’ . That BME is not yet classified in the
lassification of occupations as an independent occupation has hin-
ered its recognition at several national levels generating lack of
armonised regulations (e.g., no harmonised professional require-
ents for pursuing this profession in public hospitals in Europe).
n order to appreciate this difference, readers could compare the
ifference levels of professional recognition and regulation of BME
nd medical physics in different European countries. 
One of the reasons for ILO not considering BME in the ISCO-
8 classification in 2008 was the lack of worldwide evidence on
he number of biomedical engineers employed as either engineer-
ng or medical professionals. In fact, the ILO policy is to consider
or the ISCO classification a new occupation, if and only if, there
s evidence that more than 10 0,0 0 0 professionals are employed. In
rder to meet the ILO requirement, the chairs of the IFMBE HTAD
nd Clinical Engineering Division met in Brazil with WHO repre-
entatives for MDs in September 2017 and designed a survey aim-
ng at acquire the number of biomedical engineers employed in the
rofession worldwide. This survey was structured ( Fig. 4 ) with the
oal of optimizing the number of inquiries and maximize the col-
ection of evidence supporting the numbers of employed biomed-
cal engineers. The survey was then administered by WHO [19] ,
hich published the results in October 2018 [20] , giving evidence
f more than one million of biomedical engineers and biomedical
echnicians employed in 79 different countries. 
At the European level, the IFMBE HTAD worked in strict collab-
ration with the EAMBES (European scientific society of biomed-
cal engineers) aiming at supporting the European institutions by
roviding technical support for policy initiatives regarding medical
evices, medical facilities and related human resources. This col-
aboration was also functional to foster the promotion and stronger
ecognition of BME as an independent occupation in Europe and to
stablish the European Community of BME as valuable stakeholderor the development and revision of future European Regulations
n medical devices. Since 2014, this activity resulted in significant
chievements. 
In April 2015, the IFMBE Division and the EAMBES supported
he European Economic and Social Committee (EESC) report on
ME in publishing the first European report on BME social and eco-
omic impact [12] . This was actually a significant milestone, which
rst stated in the official Journal of the European Union the impor-
ance of biomedical engineers and the great economic and social
mpact BME is having in Europe. Moreover, this publication facili-
ated further contacts with the European Parliament and the Euro-
ean Commission. 
Following the EESC publication, the IFMBE HTAD supported the
reparation of two parliamentary questions tabled by two Italian
embers of the European Parliament (MEPs), Ms Lara Comi and
r Nicola Caputo, in July 2015. The former, asking the Commis-
ion to explain why unlike the USA, the EU research and inno-
ation program Horizon 2020 does not have a dedicated space
or supporting BME research [21] , obtained a written answer from
he Commission in October 2015 [22] . The latter, asking the Com-
ission to explain why BME is not listed among the professions
hat are officially classified by the European Commission [23] , ob-
ained a written response from the Commission in December 2015
24] . Those two parliamentary questions raised significant atten-
ion around BME needs in Europe, resulting in the launch of the
rst Euro Parliament Interest Group on Biomedical Engineering (EPIG
n BME) , on 31st of May 2016 ( Fig. 5 ). The EPIG on BME aimed at
orking with the European Commission for support the recogni-
ion of BME in Europe and focusing on 4 strategic goals: 
◦ ensuring that BME will be classified in the next revision of the
European Commission Professional Qualifications Directive; 
◦ recognizing BME scientific organisations as official stakeholders
in the Medical Devices Coordination Groups, which is the group
responsible for medical devices legislation revision in Europe; 
◦ recognizing BME as an independent research area, creating in-
dependent panels in forthcoming funding European funding
schemes and 
◦ fostering collaboration among relevant European and African
institutions aiming at harmonizing regulations on medical de-
vices, medical facilities and relevant human resources. 
Since its launch, the EPIG on BME got outstanding support from
 MEPs elected in five EU member countries: Nicola Caputo (Italy),
ara Comi (EPP, Italy), Jens Gieseke (Germany), Neena Gill (UK), Lo-
ze Peterle (Slovenia), Marijana Petir (Croatia), Davor Škrlec (Croa-
ia) and Cécile Kyenge (Italy). The EPIG on BME worked intensively
24 L. Pecchia, N. Pallikarakis and R. Magjarevic et al. / Medical Engineering and Physics 72 (2019) 19–26 
Figure 5. Launch of the first African Working Group on BME in the Africa Union 
headquarters (top-left), IFMBE delegation meeting the Ethiopian ministry of Science 
and Research (top-left and bottom photos). 
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jon those four points, achieving significant results presented in the
last EPIG on BME meeting held in October 2018. Among others,
one of the most impressive was the introduction of the BME pro-
fession in the European Skills, Competences and Occupation (ESCO)
database, which is an equivalent of the UN ILO ISCO, and, likewise,
was not yet listing BME as an independent occupation since 2016
[25] . 
While this manuscript is being written, a new EU legislature
has been elected and has been officially in place for 2 months.
Linking the newly-elected MEPs with the BME community has
started aiming at giving continuity to this very positive experience.
Regarding BME in LMICs, in collaboration with WHO, the IFMBE
has also been proactively involved in fostering BME in Africa,
creating the first IFMBE African BME working group, which was
launched in the Africa Union Headquarters in January 2018 ( Fig. 6 )
[26] . HTA has been one of the core topics for this African working
group since its launch. 
3.6. Guidelines and recommendations 
As the first important topic, the HTAD members decided to fo-
cus on HTA of MDs. It is quite well known that differences among
MDs and other healthcare technologies are substantial, and using
the same methods to assess different healthcare technologies may
lead to misleading conclusions. Starting from the table proposed in
[7] , the HTAD working group performed a systematic analysis on
which key element of MDs lifecycle should be considered in a HTA
studyand on how MDs interact with medical facilities and how this
interaction may hinder HTA conclusions. In order to achieve con-
sensus on those elements and their importance, an electronic Del-
phi study was lunched, involving 32 experts from 17 countries, 25%
of which were experienced clinical engineers and 70% HTA experts.
A grey literature review was performed, aiming at exploring how
existing guidelines on HTA of MDs consider those factors. As a re-
sult [27] , nine recommendations where given, with the purpose of
improving the assessment of MDs: 
(1) Ensure that all reasonable maintenance, installation, and on-
going facility costs are incorporated in the economic eval-
uation, or explicitly state the hypothesis of the study con-
ducted. 
(2) Describe the maintenance and installation organisational
model considered in the economic evaluation (e.g., internal
clinical engineering service). 
(3) Understand and describe explicitly in the HTA report all
possible maintenance, installation, and operational costs
considered. 
(4) Obtain additional insights on the maintenance required, and
capture maintenance impact during the HTA process by us-
ing appropriate methods of contextual inquiry. (5) Use both pre-market and post-market data to capture im-
pact of context of use variables (i.e., user, tasks, physical and
social environment) on HTA outcomes. 
(6) Conduct a risk assessment by using appropriate and vali-
dated tools or standards. 
(7) Simulate and use appropriate statistical methods to anal-
yse the different types of evidence on the effectiveness and
safety of the medical device. 
(8) Conduct, when necessary, a simulation of use to empirically
analyse safety in use and define procedures of risk reporting
and processes to mitigate residual risks. 
(9) Conduct an analytic assessment to estimate “what if” the
minimum requirements are not met. 
.7. Capacity building in LMICs 
The HTA Division members focused on supporting existing col-
aborations with the aim of: 
(1) performing scoping exercise for better understanding the
real needs of Africa in terms of BME and clinical engineer-
ing; 
(2) ensuring that ongoing initiatives properly consider HTA-
related topics. 
Over 24 months, the division supported (co-sponsored) five
eld studies in SSA countries (Benin, Ethiopia and South Africa)
nd established proactive collaboration with the IFMBE African
orking Group on BME. In addition, the division facilitated fo-
us groups and electronic surveys involving world-leading schol-
rs with experience of HTA, clinical engineering, medical device
nd medical settings. As a result, the division produced a series
f evidence-based data, which demonstrated for the first time that
he majority of researches on MDs in Africa are focused on eco-
omic and competence constrains. Conversely, very little attention
as been given to how medical devices interact with the settings
n which those are operationalised. This is mainly due to the fact
hat, although the majority of global population is still diagnosed
nd treated in low-sources settings, more than 90% of MD mar-
et is in high-income countries, namely in Europe, USA and Japan
28] . Thus, MDs are designed giving for granted that their installa-
ion and maintenance will be performed according to high-income
edical facility standards. Therefore, MDs are not resilient to low-
ncome medical settings. Accordingly, the division planned a se-
ies of training events aiming at informing African biomedical en-
ineers on the international standards given as granted from MD
esigners with the purpose of increasing their capability to: 
• recondition MDs, making them more resilient to African
working conditions (e.g., temperature, dust, humidity; non-
specialised users; 
• contribute to the definition of international standards on MDs; 
• be proactively involved in the design of medical devices and in
use ICT to support MD maintenance [29] . 
The first two training events were piloted in Benin (May 2017
nd January 2018) at the University of Abomey-Calavi. Two more
vents, namely summer schools, are planned for 2019 and 2020 in
ganda and Benin, respectively. 
.8. Continuous monitoring on BME in HTA 
The HTA Division runs several surveys and focus groups aiming
t involving international scholars, globally promoting the division
ctivities, informing on current projects and acquiring feedback
or continuously improving their execution. Those surveys were
trictly coordinated with the other priority projects and researches
unning in partner institutions. When required, ethical approvals
ere sought at the project coordinator ethical committee. Five ma-
or electronic surveys have been implemented since 2015: 
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m  • BME recommendation for HTA of MDs [27] , 
• A survey aiming at identifying factors that may hinder MD
safety and effectiveness in low-resource settings [3] , 
• A survey aiming at identifying the key priorities and finding
consensus on the priority topics to be discussed with the Eu-
ropean Parliament aiming at fostering the recognition of BME
profession in Europe, 
• A survey aiming at acquiring the number of BME and clinical
engineers worldwide and 
• A survey aiming at comparing the qualifications required to
work as a clinical engineer in European public hospitals. 
The results of these surveys have been published or submit-
ed for publication elsewhere. Nonetheless, the overarching results
chieved by this project was to highlight the importance of socio-
ogical methods in engineering, if necessary. Moreover, those sur-
eys also emphasised the need for more evidence-based clinical
ngineering for building consensus and defining international stan-
ards regarding medical devices and medical locations. 
.9. IFMBE HTA awards 
The HTA Division decided to recognize individuals and organi-
ations that contributed to the promotion and support of BME in
TA. Two awards were delivered from June 2015 to June 2018. 
The IFMBE HTAD Policy Award, awarded to policy makers
hat gave significant contribution to the recognition of BME, was
ranted to the Member of the European Parliament Nicola Caputo
or his outstanding contribution to the recognition of BME pro-
ession and for establishing the first European Parliament Inter-
st Group on Biomedical Engineering (EPIG BME) in the European
arliament. 
The IFMBE HTAD Award for Outstanding Contribution, awarded
o recognize outstanding contributions to promote or consolidate
ME involvement in HTA, was awarded to Edgardo Maria Iozia for
uthoring the EESC report on BME impact in EU (2015/C 291/07). 
.10. Reinforce the collaboration between IFMBE and WHO on HTA 
IFMBE collaborates with the WHO in matters on biomedical en-
ineering and medical devices. As a NGO in official relations with
HO, the IFMBE hosts a seat in the WHO General Assembly. The
FMBE has supported the producing several WHO reports and tech-
ical books, and has been actively involved in organisation of WHO
nternational events on health technologies. Since 2012, the IFMBE
ivision has extended this collaboration to HTA related activities.
or instance, the IFMBE members have been continuously involved
n organisation of the WHO Global Fora on Medical Devices, by
iving plenary speeches, organising workshops on HTA of medical
evices and HTA in LMICs, chairing the tracks on HTA, organising
oint events in collaboration with both, the WHO and the European
arliament [3] . 
. Conclusions 
Medical devices are intrinsically dependent on the environment
n which they are used. Consequently, HTA of medical devices is
lso intrinsically dependent on the environment where a medical
evice is required to work and this affects the generalisation of use
f HTA reports across countries, in contrast with pharmaceuticals.
TA for medical devices should therefore find its own way and
odels of conductance to respond to the large and ever-expanding
ariety of technologies involved. Medical devices are becoming in-
reasingly essential at all stages of healthcare delivery (i.e., preven-
ion, diagnosis, treatment, rehabilitation, patient management, end
f life). Therefore, HTA agencies in Europe and beyond are increas-
ng their human resources experienced in MDs. WHO recommendsmploying experts of MDs such as biomedical engineers in HTA
gencies. 
The activities described in this manuscript had a significant im-
act among the biomedical engineering community and beyond,
onsolidating the concept that HTA is a core topic for biomedi-
al engineering and that biomedical engineers are crucial actors
f HTA, especially in regards to medical devices. A proxy for this
hange in BME culture is the number of papers, round tables,
essions and tracks dedicated to HTA to biomedical engineering
vents and conferences. For instance, reviewing the proceedings
f the last four editions of the IUPESM World Congress on Med-
cal Physics and Biomedical Engineering, held in the past 12 years
espectively in Munch [30] , Beijing [31] , Toronto [32] and Prague
33] , the number of papers focusing on HTA has grown exponen-
ially. All the IFMBE conferences organised in Europe since 2016,
ad at least a whole track dedicated to HTA. Simultaneously, other
nternational societies focusing on HTA (e.g., HTAi, ISPOR, INAHTA)
ecognised biomedical engineers relevance to HTA and included
ME speakers and topics to conferences they organizing, and a col-
aborative cross-societies working group has been established to
oster global cooperation among those organisations and the WHO
34] . This is also having a direct impact on other biomedical and
linical engineering areas, which are paying unprecedented atten-
ion to HTA topics. This is certainly the case of recent studies ad-
ocating in favour of a more evidence-based approach to health
echnology management [35] and clinical engineering [36] . 
Nonetheless, more training opportunities and learning mate-
ial on HTA specifically addressing BME learning needs is clearly
eeded. The fact that the number of users of the IFMBE eLearning
latform has been growing exponentially in the past 3 years is a
ignificant proxy for this demand. 
The collaboration with the European Parliament, the EESC and
he WHO has been incredibly welcome, suggesting that there is
 real need for biomedical engineers to provide valuable inputs
o the policy-makers. Moreover, the collaboration with the WHO
nd the European Commission for fostering stronger recognition of
ME profession has given tangible results beyond our initial expec-
ation. The inclusion of BME in the ESCO has also been another im-
ortant milestone in the journey of biomedical engineering, paving
he way to more structural inclusion of biomedical engineers in
he European initiatives (e.g., creating a BME panel in framework
or excellence in research in Horizon Europe, consulting European
ME scientific societies as stakeholder for forthcoming regulations
n medical devices). Moreover, it is clear that more regulation is
equired in terms of who-can-do-what on MDs, in the best interest
f patient safety and quality of life, especially now that healthcare
ervices are becoming so dependent upon MDs. 
In 2016, the WHO concluded that Biomedical Engineering pro-
essionals can be found in 129 of 194 Member States of WHO,
ased on the input from biomedical engineers proactively involved
n national scientific BME societies and professional organisations
 8 ]. In 2017, the Survey designed by the IFMBE in collaboration
ith WHO demonstrated that we can rely on one million of
iomedical engineers and technicians employed in 79 countries
orldwide. 
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